[Initial Treatment for Cerebral Infarction]

No Shinkei Geka. 2023 Nov;51(6):1033-1039. doi: 10.11477/mf.1436204849.
[Article in Japanese]

Abstract

The treatment protocol for ischemic stroke has changed drastically in the past 20 years. In particular, the indications for recombinant tissue plasminogen activator(rt-PA)and thrombectomy have expanded. Using rt-PA or thrombectomy may be selected smoothly by receiving a call from the emergency team and efficiently collecting patient information, computed tomography scans, and blood samples. The total time required to prepare the equipment and devices should be reduced. To save as many patients as possible, a system should be established. A multidisciplinary approach is necessary from delivery to treatment to overcome the limitations of an individual doctor. Herein, we present our hospital's innovations to help other hospitals develop such systems.

Publication types

  • English Abstract

MeSH terms

  • Brain Ischemia* / therapy
  • Cerebral Infarction / diagnostic imaging
  • Cerebral Infarction / surgery
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Stroke* / diagnostic imaging
  • Stroke* / surgery
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Tissue Plasminogen Activator
  • Fibrinolytic Agents